| Identifier |
20220213_nanos_posters_192 |
| Title |
Thyroid Eye Disease Relapse After Teprotumumab Therapy: A Case Report |
| Creator |
Ricaurte R. Crespo Trevino, Francisco Sanchez Moreno, Jade Schiffman, Daniel Uribe Padilla, Rosa Tang |
| Subject |
Orbit/ocular Pathology; Ocular Motility |
| Description |
Teprotumumab is a monoclonal antibody that acts by blocking the IGF-1R and has been approved as a "breakthrough therapy" for treatment of Thyroid Eye Disease (TED). Notably, the main beneficial effects if this novel therapy is reduction in proptosis, clinical Activity score (CAS) and diplopia. As of now, there has been no description of TED relapse after Teprotumumab therapy in the literature. |
| Date |
2022-02 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2022 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS Annual Meeting 2022: Poster Session I: Orbital and Eyelid Disorders |
| Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
| Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
| Rights Management |
Copyright 2022. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6j8h187 |
| Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
| Contributor Primary |
Ricaurte R. Crespo Trevino |
| Contributor Secondary |
Francisco Sanchez Moreno, Jade Schiffman, Daniel Uribe Padilla, Rosa Tang |
| Setname |
ehsl_novel_nam |
| ID |
2063386 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6j8h187 |
